🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

Revelstoke Capital Partners
DenverGrowth
57 people
WCAS
New YorkGrowth–Late Stage
49 people
Optum Ventures
BostonSeed–Late Stage
35 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
23 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
22 people
US Venture Partners
Menlo ParkSeed–Late Stage$500K – $10M
9 people
The Innovation Space
WilmingtonPre-Seed–Seed$200K
29 people
The E14 Fund
CambridgePre-Seed–Series A$1M – $5M
16 people
Cerity Partners Ventures
BostonSeed–Late Stage
21 people
Madrona Venture Labs
SeattlePre-Seed–Series C
61 people
Vermont Center for Emerging Technologies (VCET)
BurlingtonPre-Seed–Series A$25K – $250K
23 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
AgFunder
San FranciscoSeed–Growth$10K – $5M
24 people
Rev1 Ventures
ColumbusPre-Seed–Series A
47 people
PharmStars Ventures
BostonPre-Seed–Seed
23 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
32 people
Pappas Capital
DurhamPre-Seed–Late Stage
34 people
ID Ventures
DetroitPre-Seed–Series A$50K – $250K
9 people
LOWERCARBON
JacksonPre-Seed–Growth$1M – $50M
17 people
Northpond Ventures
BethesdaSeed–Series A$100K – $5M
39 people
Ampersand
BostonGrowth
36 people
Breyer Capital
AustinPre-Seed–Growth$500K – $10M
9 people
Colle Capital Partners
New YorkPre-Seed–Series A$500K – $2M
30 people
Olive Tree Capital
BostonSeed–Late Stage
6 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.